Novo Nordisk organize a yearly case competition in which a heterogeneous group of individuals are grouped into 8 teams of 6 individuals and are asked to tackle one of Novo Nordisk pressing challenges. The heterogeneity among team members provides a vibrant atmosphere and a dynamic environment with lots of discussions a on potential solutions to the case posed. This year the topic of the challenges regards a pharmacological solution to the health risk of obesity. Participants are asked to reconsider how we think about obesity and come up with a solution on how to convince medical doctors to treat obesity pharmacologically. This year, Prof. toke Reichstein participates as a member of a panel that guides the students through the process of coming up with solutions.